Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   FEYZ   JUNE 2016 , Volume 20 , Number 2 ; Page(s) 180 To 187.
 
Paper: 

SURVIVAL ANALYSIS OF BREAST CANCER CASES UNDER THE REGIMENS OF ANTHRACYCLINE ALONE AND COMBINAED WITH TAXANES (2004-2012)

 
 
Author(s):  EHSANI M., ATOOF F.*, NASRI N.
 
* DEPARTMENT OF BIOSTATISTICS AND EPIDEMIOLOGY, FACULTY OF HEALTH, KASHAN UNIVERSITY OF MEDICAL SCIENCES, KASHAN, I.R, IRAN
 
Abstract: 

Background: Breast cancer (BC) is the most common cancer among women. Early diagnosis, treatment and prevention of BC is among the most debated topics in the world. Early diagnosis and appropriate treatment of BC can decrease the mortality rate to 2.2% per year. The aim of this study was to analyze the survival of patients with BC treated with anthracycline alone and combined to Taxane.
Materials and Methods: In this historic cohort study the BC cases (n=160) referred to oncology clinics during 2004-2012 were divided to two treatment groups (Anthracycline alone and Anthracycline+Taxane). Patients were followed-up until death or exclusion from study. On demand, every 6 months a bone scan and CT was taken; every 3 months using blood tests the cases were followed-up. The samples were analyzed for estrogen, progesterone and HER2 Neu receptor and then survival analysis.
Result: All cases (n=160) were divided into two equal treatment groups (Mean age: 47.4 years). While no significant difference was found between the two groups for age, estrogen, progesterone, HER2 Neu receptor, size/type of tumor, number of lymph node and metastasis rate, the mortality and exacerbation rates in Anthracycline group (12.5% and 7.5%, respectively) was significantly higher compared toTaxane group (3.8% and 0, respectively). In addition, the survival rate in Taxane group was higher.
Conclusions: Use of Taxane for BC reduces the mortality and exacerbation rates but increases its survival rate and life expectancy.

 
Keyword(s): SURVIVAL RATE, ANTHRACYCLINE, TAXANE, BREAST CANCER
 
 
References: 
  • ندارد
  •  
 
Click to Cite.
APA: Copy

EHSANI, M., & ATOOF, F., & NASRI, N. (2016). SURVIVAL ANALYSIS OF BREAST CANCER CASES UNDER THE REGIMENS OF ANTHRACYCLINE ALONE AND COMBINAED WITH TAXANES (2004-2012). FEYZ, 20(2 ), 180-187. https://www.sid.ir/en/journal/ViewPaper.aspx?id=568823



Vancouver: Copy

EHSANI M., ATOOF F., NASRI N.. SURVIVAL ANALYSIS OF BREAST CANCER CASES UNDER THE REGIMENS OF ANTHRACYCLINE ALONE AND COMBINAED WITH TAXANES (2004-2012). FEYZ. 2016 [cited 2021May15];20(2 ):180-187. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=568823



IEEE: Copy

EHSANI, M., ATOOF, F., NASRI, N., 2016. SURVIVAL ANALYSIS OF BREAST CANCER CASES UNDER THE REGIMENS OF ANTHRACYCLINE ALONE AND COMBINAED WITH TAXANES (2004-2012). FEYZ, [online] 20(2 ), pp.180-187. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=568823.



 
 
Yearly Visit 36 Persian Abstract
 
Latest on Blog
Enter SID Blog